Established in 2012, EndoTech successfully provided proprietary algorithms for hedge funds. Our vision has always been to help both retail and institutional clients to take control over the trading process and risks by developing and constantly improving our software.
Due to unprecedented crypto market growth, we added cryptocurrency analysis tools to our product line. We were the first to provide a cohesive and actionable set of Artificial Intelligence and Machine Learning techniques to service the blockchain-based investment market.
In 2020, we re-invented our approach by making ETBot a stand-alone product for our individual (retail) clients.
ETBOT - Empowering your trading routine and results 24/7
The first cohesive and actionable set AI/ML techniques to service the blockchain-based investment market.
Manual trading signals emailing launched for Institutional subscribers only.
Fully automated EndoTech portfolio strategy execution via secure API key terminal connection.
All portfolios and performance published. First media coverage of EndoTech senior team and products.
Brand new platform design with technical analysis tools, includes newly released portfolios exclusive to Retail clients.
Platform launched for Institutional clients investing in crypto markets. First Alpha & Beta portfolios of cryptocurrencies released.
Scalable portfolios. Compound returns delivered via API key connection to the top-10 trading exchanges.
EndoTech 2018 crypto Alpha portfolio performance reaches +575% for Retail subscribers.
Regulated liquidity and full OTC solutions launched for Retail & Institutional clients. New OTC portfolio strategies created and initiated for off exchange settlement.
Set of ETBot Alpha & Beta portfolios for Retail clients released as scalable solutions. Compound returns delivered via API key connection to the top-10 trading exchanges.
EndoTech.io website converted to Institutional clients servicing exclusively. Mass Institutional & Retail client development program launched to build higher system AUM connectivity.